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Abstract
Background: Experience-based co-design (EBCD) brings patients and staff together 
to co-design services. It is normally conducted in one organization which initiates and 
implements the process. We used the traditional EBCD method with a number of 
adaptations as part of a larger research study in the British National Health Service.
Methods: The primary aim was to assess the feasibility and acceptability of conduct-
ing research-initiated EBCD, to enhance intervention development prior to testing. 
As well as embedding the method in a research study, there were 3 further key adap-
tations: (a) working across primary and secondary care sectors, (b) working on multi-
ple sites and (c) incorporating theory-informed analysis.
Results: We recruited four sites (covering both primary and secondary care) and, on 
each site, conducted the initial traditional EBCD meetings, with separate staff and 
patient groups—followed by a single joint patient-staff event, where four priority 
areas for co-design were agreed. This event was driven by theory-informed analysis, 
as well as the traditional trigger film of patient experiences. Each site worked on one 
priority area, and the four co-design groups met over 2-3 months to design prototype 
tools. A second joint event was held (not usually undertaken in single-site EBCD) 
where they shared and compared outputs. The research team combined elements 
of these outputs to create an intervention, now being tested in a cluster randomized 
controlled trial.
Conclusions: EBCD can be successfully adapted for use across an entire patient 
pathway with multiple organizations and as part of a research process to identify an 
intervention for subsequent testing in a randomized trial. Our pragmatic approach 
used the patient experience to identify areas for improvement and co-designed an 
intervention which directly reflected patient priorities.
K E Y W O R D S
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1  | BACKGROUND
1.1 | Experience-based co-design in health service 
improvement and research
Experience-based co-design (ECBD) has been shown to be a powerful 
tool for developing health service improvements—and acceptable to 
both service users and staff 1-3. Based on a narrative-based participa-
tory approach, the method is designed to lead to service improve-
ments by bringing together staff and service users to collaboratively 
co-design services.4 Since the first reported use of EBCD in 2007,5 a 
2014 review identified over 59 projects in six countries—usually within 
a single health-care organization.6 At the centre of the method is a 
‘trigger film’ of patients talking about their experiences to stimulate 
joint discussions between patients and staff around service delivery 
issues. These discussions focus on identifying priorities for improve-
ment and are followed by co-design groups to develop prototype solu-
tions. Such videos can be highly effective, facilitating collaboration of 
participants with different perspectives.7 EBCD was first described in 
a ‘tool kit’ from the Kings Fund and is now housed at the Point of Care 
Foundation.8 Health service researchers have recognized the impor-
tance of co-designed interventions; however, at the time of our study 
(2016), there were no published studies that reported using EBCD in 
intervention development for evaluation in a randomized control trial 
(RCT). Therefore, our paper makes a novel and timely contribution to 
the further development of participatory methods.
1.2 | Adapting the EBCD method
A particular appeal of EBCD is the ability to adapt it to particular cir-
cumstances. With any such adaptations, the importance of retaining 
the patient interviews and interaction between patients and staff 
has been emphasized.6 Whilst designing a study to develop an inter-
vention to be tested in a randomized controlled trial, we identified 
that as well as being a service improvement tool, EBCD could also be 
powerful as an integral part of the research process to help identify 
a patient-centred intervention. Hence, we designed and operation-
alized an adapted EBCD as a key part of intervention development. 
This paper, therefore, describes a study within a larger study.
Our novel approach also included:
• working with a group of 9 British National Health Service (NHS) 
health-care providers (including both primary and secondary care 
sectors) covering four distinct geographical areas (each with a 
population of between ~450 000 and 750 000). In this paper, we 
will describe each of these four sites as ‘health-care economies’.
• undertaking the process on four sites—rather than the usual sin-
gle site
• augmenting the trigger film through systematic analysis using re-
silience and systems theories (drawing on data collected in a pre-
ceding mixed-methods study—observations, document analysis 
and interviews together with a systematic review9).
1.3 | Developing an intervention for managing 
medicines at transitions of care
The focus of our study was addressing the problems associated 
with how medicines are managed at transitions of care—spe-
cifically when cardiology patients are discharged from hospital.9 
Despite very strong evidence of effectiveness of medicines in 
heart failure, outcomes for heart failure continue to be sub-opti-
mal and survival rates have not improved in line with other health 
conditions.10 We found no previous studies that had used EBCD 
to explore medicines management for heart failure patients. Our 
planned RCT was to be conducted in 42 areas of England, and the 
engagement of multiple sites was critical to intervention develop-
ment. After considering a range of co-design methods, we con-
cluded that an EBCD process adapted for multiple sites would best 
meet the needs of the larger study.
1.4 | Aims and objectives
This paper aims to assess the feasibility and acceptability of health 
service researchers co-leading EBCD in multiple health-care settings 
as part of intervention development.
The objectives are to:
1. Examine the feasibility of implementing the EBCD process in 
a health service across health-care organizations on different 
sites and in different settings (both primary and secondary 
care) and integrating existing theory
2. Determine the acceptability of patients, researchers, quality im-
provement (QI) leads and clinicians working together to develop 
an intervention.
3. Identify the challenges for different participants specific to their 
ambitions, organizational processes or outcomes.
2  | METHODS
2.1 | EBCD in the ISCOMAT study
The EBCD was embedded within the design of a wider UK pro-
gramme of research:
• This research was leading to a large national randomized con-
trolled trial of an intervention.
• ‘Improving the Safety and Continuity of Medicines management 
at Transitions of care’ (ISCOMAT) was designed to study medi-
cines management for patients with heart failure across a range of 
health organizations involved in their care in the National Health 
Service (NHS).11
• The focus is on working with patients and health-care staff to de-
velop and test a toolkit to improve the management of medicines 
when patients move between hospital and home.
     |  3RAYNOR et Al.
Figure 1 shows the ISCOMAT study summary showing the con-
text of the EBCD.
2.2 | The EBCD Procedure
We drew on previous work undertaken by the King's Fund and oth-
ers to adapt the EBCD process.12 The steps in the traditional EBCD 
process are listed in Figure 2:
In order to reflect diversity, we ensured that the 4 sites cho-
sen represented a mix of urban, rural and coastal locations and 
consisted of both large teaching hospitals and smaller district 
general hospitals. All sites contained both deprived and affluent 
areas, and three were in areas that contained ethnically diverse 
populations. The sites were located within a 60 mile geographical 
radius from the research team's base to facilitate data collection 
and minimize the travel burden for both health professionals and 
patients.
F I G U R E  1   ISCOMAT study summary 
showing the context of the EBCD
WP1: Case study and systematic review: Mixed methods to map and evaluate the 
heart failure medicines pathway from discharge to primary care in four health-care 
areas: observations (190 hrs of hospital ward observations) and documentary 
analysis in hospitals, interviews with staff (45 from hospital staff and primary care 
including GPs, community heart failure nurses, community pharmacists) and 20 
patients (at discharge and then at two later time points). Patient interviews were 
filmed to produce a EBCD trigger film. A systematic review was undertaken of 
interventions to improve continuity of medicines management for patients discharged 
from hospital. 11
WP2: Intervention development: Using the MRC framework, a patient-centred 
intervention was developed through an adapted EBCD process, incorporating the 
outputs of the prior case study. Multiple sites participated (four) with each site co-
design team working on one of the four identified priorities, supported by a co-design 
expert from Point of Care. We ‘user tested’ the co-designed outputs and modelled an 
intervention informed by behaviour-change theory and the outputs of the systematic 
review. 
WP3: Feasibility study: We assessed the intervention for usability and 
acceptability, refined the intervention and established an effective implementation 
process, and determined the feasibility of data collection for economic evaluation. 
WP4: Randomized trial: Evaluation of the effect and cost-effectiveness of the 
intervention in a multi-centre cluster randomized trial (42 sites in England, 2100 
patients), with an embedded process evaluation. 15
F I G U R E  2   Steps in the traditional 
EBCD process
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For each of the four sites invited to take part in the EBCD, 
the research team established the internal organizational process 
for quality improvement (QI) to enhance organizational benefit 
through the potential for collaborative working. The team then 
approached the lead for that process to secure engagement. 
Training on conducting EBCD was delivered by the Point of Care 
Foundation for the:
• research team
• ISCOMAT patient-led steering group members and
• sites’ quality improvement leads
Following this, a local champion was identified for each of the 
four sites. These comprised: site 1: quality improvement man-
ager; 2: hospital cardiology pharmacist; 3: research nurse; and 4: 
cardiologist.
An earlier work package in the larger study had recruited the 
four sites as research settings, and we invited all patients who had 
been interviewed about their experiences of receiving heart failure 
medicines to take part in the EBCD process (see ‘theory-informed 
analysis’ below). Sixteen patients and family members, and 24 staff 
members participated in the patient and staff meetings at the four 
sites. Table 1 lists the patient event participants and Table 2 the 
staff event participants. The joint event was co-facilitated by a pa-
tient representative and a professor of cardiovascular health, with 
support from an expert in EBCD and a researcher working with the 
ISCOMAT patient-led steering group. It was attended by 34 par-
ticipants (17 patients and carers, 13 health professionals and four 
others). Table 3 lists the participants of the first joint event. It was 
co-chaired by a patient and a consultant cardiologist. In addition, 11 
research team members were in attendance.
The 20 patients and 45 staff who had participated in the four case 
study areas were invited to the separate EBCD events for patients and 
for staff—at each of the four sites. Events were facilitated by two mem-
bers of the research team with previous experience of working with 
patients and health-care professionals. An external facilitator (HB) 
from the Point of Care Foundation who advised on event design was 
present at the events and provided design support to the co-design 
groups. In producing the trigger video, the research team worked with 
the patient-led steering group, notably its chairperson.
Our EBCD included three key adaptations:
1. Working across health-care organizations and between four 
health-care economies—EBCD generally takes place in one 
organization, whereas here both hospital teams and primary 
care (including general practitioners, pharmacists and heart 
failure nurses) are critical to successful medicines management 
in heart failure and were included in the co-design process.
2. Working with multiple sites—Traditionally, EBCD takes place 
within the confines of one site. However, we were aware that 
different models for managing heart failure and associated medi-
cines existed across NHS local systems and set out to capture 
this within intervention development. In the previous case study, 
we purposively selected four health economies and within a 60-
mile catchment area of the most centrally located site. Patient 
and staff EBCD meetings were held at each of the four sites. A 
feedback summary was produced from each of these eight meet-
ings, and we then held a multi-site joint patient/staff meeting 
that considered the insights and areas for opportunity that had 
emerged.
Participants then generated a long list of priorities relating to 
areas that could be improved and then agreed key priorities to 
take forward in the co-design process. This was an important 
adaptation to the traditional EBCD approach, where tradition-
ally one design solution would apply to a single site. After the 
joint meeting, the co-design work was undertaken by four local 
groups (each led by the local site champion) who led the devel-
opment and prototyping of tools to form part of the interven-
tion, supported by the experienced Point of Care Foundation 
facilitator. Finally, we reconvened the multi-site meeting, bring-
ing co-design group members together to present their results 
to each other.
3. Incorporating theory-informed data analysis—Traditionally, 
EBCD involves some observations of the delivery of care and in-
terviews with patients and staff. The quantity of data collected 
is variable and often subject to local resource constraints. Our 
research study allowed for a larger data collection and analysis 
exercise which included ward observations and staff and patient 
qualitative interviews. We adopted a ‘Safety II’ approach which 
acknowledges that despite a considerable focus on learning from 
adverse events in health care, achieving extensive improve-
ments in the safety of care has been slow.13 Safety II accepts the 
complexity of health care and prioritizes learning from the safe 
delivery of care to patients and how they can play a key role in 
their own safety.14 We were able to present our analysis to pa-
tients and staff at our separate and joint events to inform their 
view of the system and the positive roles they played within it, 
whilst highlighting the potential for safer care through system 
modification.9 Staff, in particular, were receptive to the posi-
tive perspective of Safety II, which demonstrated how they and 
their colleagues were flexible and adaptable in the face of pres-
sure to promote safer outcomes for patients, even where their 
actions were not necessarily mandated or recognized by their 
organizations.
Figure 3 shows the adapted EBCD process used in this study in 
flow chart format.
TA B L E  1   Patient event participants
 Patients Family members/carers
ISCOMAT 
PLSG members
Site 1 2 1  
Site 2 3 2  
Site 3 2 2 1
Site 4 3 1 1
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3  | RESULTS
3.1 | Feasibility and acceptability of process to 
participants across health-care organizations and in 
multiple sites
Having successfully negotiated with the four sites, all of which 
agreed to participate in the EBCD project, the patients and staff re-
cruited took part in patient and staff meetings at each site. At the 
joint meeting, feedback presentations were used to explore insights 
and areas for opportunity for improvement. The participants gener-
ated a long list of 15 priority areas which they then grouped and 
narrowed down to their top four. Figure 4 lists the priorities jointly 
agreed at the first joint patient/staff meeting. This showed that hav-
ing patients and staff working together on multiple sites—and then 
coming together at a joint meeting—could successfully generate pri-
orities for the subsequent co-design work.
As part of the joint meeting, it was agreed which site would 
work on which priority and the members of the respective co-de-
sign teams for each site were identified. In total, 12 patients and 
16 staff members were part of the local co-design teams. Each 
team consisted of four to seven individuals, who were asked to 
develop a tool that would address their team's priority and they 
met at their individual sites over a 2- to 3-month period. The 
teams identified opportunities to improve the service or the care 
pathway related to their priority area and designed prototype 
‘tools’.
Finally, the tools designed at each site were shared in a second 
central joint meeting of staff and patients from the four areas to-
gether with members of the research team. The second joint event 
was attended by 15 participants (10 patients and carers, four health 
professionals and a quality manager), along with 6 members of the 
research team. Table 4 lists the participants in the second joint event.
Such a second joint meeting does not normally take place in 
single-site EBCD. However, as our co-design teams were working 
separately on tools to address different priorities within the care 
pathway, the multi-site EBCD processes required an additional 
event to enable the teams to share and compare their outputs, 
along with any plans they had to implement their tools locally. We 
also observed during this second event how the separate teams 
took pride in presenting their tools to the larger group and how 
they enjoyed further contact with those they had shared their 
ideas and experiences with at the earlier joint event. Our infor-
mal observations at each event enhanced our view that invited 
participants were fully engaged in the process. The joint conver-
sations suggested that the various team members—representing 
disciplines and roles that do not routinely have the opportunity to 
dissect the medicines management process—valued the protected 
time and space to work on practical and pressing challenges, but 
significantly, with patients.
 
Specialist HF 
nurses GPs
HF 
consultant Pharmacists Other
Site 1 3 1 1  1 (Palliative care consultant)
Site 2 1 2 1 1 2 (Cardiology Business 
Manager; Research nurse)
Site 3 2 1  1 4 (NHS Trust Quality 
Improvement 
Manager; CCG: Senior 
Commissioning Manager; 
Quality Manager; Senior 
Quality Officer)
Site 4 1   2  
TA B L E  2   Staff event participants
TA B L E  3   First joint event
 Patients
Family 
members/
carers
Health 
professionals Others
Site 1 2 1 3 -
Site 2 3 2 4 -
Site 3 - - 3 1 (Commissioning 
Pharmacist)
Site 4 2 2 2 2 (Quality Manager & 
Project Officer)
Patient Led 
Steering Gp
5    
CCG   1 1 (Head of Research)
Note: The first joint event was attended by 11 research team members, 2 invited academics, a 
guest co-presenter (Professor of Cardiovascular Health) plus the following 34 participants.
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Our records of attendance served as a proxy measure of accept-
ability concerning the EBCD process.
3.1.1 | Use of theory-informed data analysis to 
support the EBCD process
The trigger film drew upon 55 interviews with 20 patients (at dis-
charge, then 2 and 6 weeks later). In addition to the trigger film, a pres-
entation which summarized key findings from the prior case study was 
included at the first joint event, based on a resilience-informed analysis 
and including the findings from the systematic review. The presenta-
tion followed the patient journey and detailed what makes the system 
more and less resilient. The case study identified variations in the way 
health care was structured and delivered in the four areas. For exam-
ple, specialist heart failure nurses performed domiciliary visits in some 
areas but not in others, and due to staff availability, the typical waiting 
period for the first visit post-hospital discharge ranged from 21 days to 
12 weeks. The data in this presentation were then successfully incor-
porated into the discussions which followed.
After the second joint event, the research team were able to 
combine elements from each of the outputs to create an intervention 
for heart failure patients at discharge from hospital. The creation of 
the intervention and its use within our RCT are described in detail 
elsewhere,11 but briefly the ‘Medicines At Transitions Intervention’ 
consists of:
1. Online training to secondary care cardiology, community phar-
macy and primary care staff about discharge management (in-
cluding medicines).
2. Patient-held information.
3. Delivery of education to patients about their medicines.
4. Enhanced communication between hospital and the patients’ 
community pharmacists
5. Increased engagement of community pharmacists with patient 
care after discharge
3.1.2 | Integrating with local quality 
improvement processes
Processes for approving and leading quality improvement varied 
across the four sites. For example, in a large teaching hospital, 
responsibility for innovation was devolved to clinical directo-
rates, but in a district general hospital, a central panel approved 
changes and had a fixed, multi-step process. Patient engagement 
and structured facilitation were key to ensuring the co-design 
process was effective when working with service improvement 
leads and alongside existing processes or initiatives designed to 
deliver quality improvements and drive transformational change. 
The EBCD process was particularly well received in one site, as 
F I G U R E  3   Flow chart for the adapted EBCD method
Four sites identified 
Prior case study and systematic review 
- Observations 
- Patient and staff interviews 
- Documentary analysis 
- Systematic review 
Production of Trigger film 
Patient events (x4) 
Staff events (x4) 
Joint event 
Co-design groups meet over 2-3 mo
Second joint event 
F I G U R E  4   Priorities agreed at the first joint patient/staff 
meeting
1. Improve communication between various professionals 
2. Better explanation in hospital about their tablets and condition the day prior to 
discharge. 
3. Improve patients’ understanding about what will happen after discharge. 
4. Improve communication about the plan at home (who does what & when) 
TA B L E  4   The second joint event was attended by 6 research team members plus the following 15 participants (10 patients and carers 
and 5 staff members)
 Patients Family members/carers Health Professionals Others
Site 1 1 1 1 -
Site 2 1 - 1 -
Site 3 - - 1 -
Site 4 2 2  1 (Quality 
manager)
CCG   1 -
Patient Led Steering Gp 3    
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it enabled them to achieve a national target of increasing patient 
engagement.
After identifying and engaging a key local decision-maker and 
agreeing on the EBCD process, sites took on board the relevance 
and potential value of the project. The local champions’ participa-
tion in joint EBCD training with the research team helped to build 
rapport and working relationships between NHS organizations and 
the research team and contributed to organizational development 
for service improvement teams.
3.2 | Challenges
We faced a number of challenges in planning and implementing the 
EBCD process in the partnering sites. These ranged from the purely 
logistical, for example finding suitable locations to hold events and 
developing focussed activities to engage both patients and health 
professionals in purposeful conversations.
Other challenges involved retaining the interest of both par-
ties (service users and health professionals) over a sustained pe-
riod and managing expectations and outcomes; EBCD projects are 
often expected to deliver tangible quality improvement outcomes 
quickly and cost-effectively.15 Aligning patients’ expectations and 
motivation to improve their lived experience of the service with 
health professionals’ work routines and their need to implement 
measurable quality improvements also proved challenging. We 
addressed this by recognizing the inevitable ‘power imbalance’ 
that exists within EBCD and by championing the voice of the ser-
vice users by ensuring that our whole approach hinged on a pa-
tient-centred redesign process.
4  | DISCUSSION
By using EBCD methods in multiple locations, the input of patients 
and providers was able to support patients and staff to agree to 
a common set of priorities with respect to medicines manage-
ment in heart failure patients. Despite differences in the local 
care pathways for patients discharged from hospital with heart 
failure, patients and staff were able to identify key priorities that 
applied across all four of the NHS patient pathways. Furthermore, 
although sites were allocated different priorities to work on, they 
valued the opportunity to come together and learn from the expe-
riences of other sites.
It has been noted that practical advice on how and when to 
use EBCD is limited16 and our findings fill some of these gaps, no-
tably that it is feasible and acceptable to conduct research-initi-
ated multi-site EBCD to enhance intervention development in a 
study of heart failure medicines management. This reframing of 
the process resulted in the creation of an intervention which is 
currently being tested in a randomized trial. We used EBCD to 
help us understand what needed to change and to develop some 
co-designed prototypes for how these changes could be brought 
about. We argue that multi-site co-production methodologies can 
enhance intervention development and provide a mechanism to 
translate available evidence into patient-centred, intervention 
proposals.
Our adaptations to the traditional EBCD approach yielded unex-
pected benefits and created a clear process for co-learning. Our in-
clusion of a second joint meeting to share and discuss the prototype 
tools developed by the co-design groups enabled them to share their 
findings, and we suggest this additional step is essential in multi-
site EBCD. Richard et al noted that engagement is essential in tri-
als’ research but rarely embedded across all stages of the research 
continuum.17
Our work has identified issues related to researchers engag-
ing with participating organizations’ processes for approving and 
leading innovation, including NHS quality improvement leads. We 
encountered several challenges in organizing and conducting the 
EBCD process which have been noted by other researchers: power 
to authorize change, commitment to the process, methods for 
gathering experiences, designing improvements, implementation 
and subsequent impact.7,15 At each site, we explored the hospital's 
own process for service improvement and the individual(s) that 
made decisions. We found that quality improvement structures, 
processes and responsibilities were much clearer in NHS hospitals 
than in their adjoining primary care settings. As our intervention 
was initiated in the hospital setting, this meant we were able to 
work within the existing systems. Organizational commitment 
and internal power were considered through our initial identifi-
cation of an individual with the power to grant authorization for 
the EBCD process. The local champions provided organizational 
commitment, and their enthusiasm and drive were critical in the 
co-design groups’ completion of their tasks. For any EBCD proj-
ect to be successful, it should be championed by individuals who 
are strong leaders and have the authority to drive change in their 
organizations.
The collection and analysis of local data by the research team 
removed a key barrier in EBCD by providing resources for robust 
and systematic data. The collection and analysis of local data by the 
research team removed a key barrier in EBCD by providing resources 
for robust and systematic data. However, although sharing these 
data with local teams was undoubtedly powerful, some patients and 
staff may have felt that their original thinking was somewhat primed. 
The contribution of the research team in facilitating EBCD cannot 
be underestimated, as the sites we worked with had no previous 
experience of using EBCD to engage with patients. We not only in-
troduced organizations to EBCD, but we also guided them through 
each stage and undertook the most challenging part of the process—
the recruitment of patients and the creation of the trigger film. We 
found that local quality improvement teams did become engaged in 
the process, and the research team coordinated their involvement 
across the four areas.
In the future, local teams might themselves collaborate across 
sites in EBCD. Oversight and coordination might work through 
existing networks—for example in the NHS via Academic Health 
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Science Networks18 which bring together British universities and 
NHS health-care providers to innovate at pace and scale at regional 
level. Our trigger film is now in use nationally in a patient safety pro-
gramme across networks. Such systematic collaboration might also 
facilitate shared QI initiatives at a system level in Integrated Care 
Partnerships,19 a current policy priority across the NHS in England. 
Perhaps the key message is that researchers and QI teams could 
collaborate and build this in from the research planning stage. This 
might be particularly helpful in patient safety studies, a topic that 
has a well-established relationship with QI.
Unusually for a study using co-design in intervention develop-
ment, our project included all five key EBCD elements:
1. inclusion of the full range of stakeholders,
2. involvement of users throughout the study,
3. inclusion of the whole service,
4. focus on user experience and
5. consideration of the implications for the interface between users 
and service providers.
We found only one published study of the use of co-design in 
intervention development for heart failure management and that 
utilized ‘expert’ health-care professionals known to the research-
ers rather than those involved in delivering care in the organiza-
tion from which patient participants were recruited.20 Richard et 
al reported that relatively few studies report on the engagement 
of public, patient and/or service users across the research contin-
uum.17 Our paper makes a valuable contribution to sharing meth-
ods of active joint working between researchers, NHS patients 
and staff, beyond simply collecting data to co-producing a new 
intervention.
Clarke et al have noted the lack of rigorous evaluation of the 
impact of EBCD in acute health-care settings and recommended 
that future studies should evaluate clinical and service outcomes.21 
Only one feasibility RCT evaluating the impact of a co-designed 
intervention to improve the knowledge, experience and emotional 
well-being of carers of people with breast, lung or colorectal can-
cer reported the use of a validated outcome measure, the General 
Health Questionnaire.21
4.1 | Limitations
Informal discussions with the two sites that continued, after the 
EBCD, to offer participation in the RCT feasibility study have since 
indicated that neither had adopted the intervention beyond the 
study period itself. In this respect, although the EBCD was success-
ful as a method of intervention development it seems to have had 
little impact on practice. Dimopoulos-Bick et al in their review note 
that there is little evidence about the wider impact of experience 
systems.15 We had hoped that the process would have led to lasting 
changes at each of the sites—and although this did not occur, our ex-
perience suggests it is not indicative of any weakness in commitment 
during the EBCD process itself. Others who may wish to adopt this 
approach might spend more time securing and ratifying senior man-
agement support as part of the planning process. Additionally, we 
are uncertain about the feasibility of implementing this process in 
countries where local health economies lack a history of collabora-
tive working.
5  | CONCLUSION
EBCD has previously been shown to work in a single site and usu-
ally with a single organization. We have shown that EBCD can be 
successfully adapted for use across an entire patient pathway with 
multiple organizations and between health economies. Each team 
across the four sites delivered a new tool that addressed the con-
cerns identified in priority areas for patients and staff.
Multi-site EBCD is a novel and valuable collaborative approach 
to service improvement and has the potential to enhance the effec-
tiveness of service development across organizational and physical 
boundaries. Our pragmatic approach in using EBCD is that we have 
not only used patient experience to identify areas for improvement 
but have co-designed an intervention directly reflecting patients’ 
priorities to be tested in a cluster randomized control trial that seeks 
to provide evidence for or against adoption.
As in traditional EBCD, we showed that patients and health-care 
professionals can work together to identify and implement changes 
that benefit both service providers and end users. Furthermore, 
enhancing communication between patients and health-care pro-
fessionals resulted in mutual learning and respect for each other's 
viewpoints. Moreover, it may help to erode the traditional power 
imbalance between the two parties.
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